Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
The DOI matches its Crossref record.
Abstract
Statins are pluripotent agents exhibiting multiple non-lipid-lowering actions. Besides their established role in the management of hypercholesterolemia, statins may also have beneficial actions in other pathological conditions, namely: a) osteoporosis and osteoporosis-related bone fractures, b) cancer, c) solid organ transplantation, d) cerebrovascular events (transient ischemic attack and stroke episodes), e) various neurological disorders, such as Alzheimer's disease, Parkinson's disease and multiple sclerosis, f) cardiac arrhythmias and heart failure, g) renal diseases, h) rheumatoid arthritis, i) autoimmune diseases, j) sepsis, and k) allergic asthma. We reviewed the literature searching for studies that support or oppose the use of statins in each proposed indication. In some of these emerging indications, a role for statin treatment is more firmly set; for others, current evidence is more controversial. Future trials may reveal more convincing evidence that will make statin use necessary in the therapeutic management of several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they may exert benefit in a huge variety of syndromes [838]”
Citations
Cites
Still being checked.
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
S. Antonopoulos, A., Margaritis, M., Lee, R., Channon, K., & Antoniades, C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504803 · Cited by 432
Anti-Inflammatory Agents for Cancer Therapy
Rayburn, E. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.05 · Cited by 341
Vascular calcification and bone disease: the calcification paradox
Persy, V., & D’Haese, P. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.001 · Cited by 332
Metadata
- Authors
- Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-12-01
- Volume
- 13
- Issue
- 35
- Pages
- 3622-3636
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2164463284
- Cited by
- 70
- References
- 0
- Citations by year
- 2024: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 10
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- statins, off-label drug use, osteoporosis, bone fractures, cancer, solid organ transplantation, cerebrovascular disease, stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, multiple sclerosis, cardiac arrhythmias, heart failure, kidney disease, rheumatoid arthritis, autoimmune disease, sepsis, allergic asthma
- MeSH terms
- Animals, Antineoplastic Agents, Arthritis, Rheumatoid, Asthma, Autoimmune Diseases, Cardiovascular Agents, Cerebrovascular Disorders, Heart Diseases, Humans, Kidney Diseases, Neoplasms, Nervous System Diseases, Osteoporosis, Organ Transplantation, Antirheumatic Agents, Neuroprotective Agents, Sepsis, Anti-Asthmatic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications. https://app.cochat.ai/papers/10.2174/138161207782794194
- The paper
- Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D. (2007). Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications. Current Pharmaceutical Design. https://doi.org/10.2174/138161207782794194
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.